Logo

Vol. 128, No. 1

January 30, 2018
On this page
Leukotrienes and residual inflammatory risk in coronary artery disease
Magnus Bäck
Pol Arch Intern Med. 2018, Vol. 128, No. 1: 1–3; DOI: 10.20452/pamw.4196
Long‑term management of patients with chronic obstructive pulmonary disease who undergo percutaneous coronary intervention still needs to be dramatically improved
Mario Cazzola, Paola Rogliani, Maria G. Matera
Pol Arch Intern Med. 2018, Vol. 128, No. 1: 4–6; DOI: 10.20452/pamw.4197
Using simple blood count for the diagnosis of pulmonary embolism in chronic obstructive pulmonary disease exacerbations: are we there yet?
Andriana I. Papaioannou, Spyros Papiris, Konstantinos Kostikas
Pol Arch Intern Med. 2018, Vol. 128, No. 1: 7–8; DOI: 10.20452/pamw.4195
Association between bone remodeling and inflammatory markers in obstructive sleep apnea in relation to disease severity
Barbara Bromińska, Ewa Cyrańska-Chyrek, Barbara Kuźnar-Kamińska, Magdalena Kostrzewska, Hanna Winiarska, Nadia Sawicka-Gutaj, Ariadna Zybek-Kocik, Aleksandra Hernik, Elżbieta Wrotkowska, Zbigniew Krasiński, Marek Ruchała, Halina Batura-Gabryel
Pol Arch Intern Med. 2018, Vol. 128, No. 1: 9–14; DOI: 10.20452/pamw.4143
Monocyte to large platelet ratio as a diagnostic tool for pulmonary embolism in patients with acute exacerbation of chronic obstructive pulmonary disease
Adam J. Białas, Kamil Kornicki, Maciej Ciebiada, Adam Antczak, Przemysław Sitarek, Joanna Miłkowska-Dymanowska, Wojciech J. Piotrowski, Paweł Górski
Pol Arch Intern Med. 2018, Vol. 128, No. 1: 15–23; DOI: 10.20452/pamw.4141
Chronic obstructive pulmonary disease affects the angiographic presentation and outcomes of patients with coronary artery disease treated with percutaneous coronary interventions
Rafał Januszek, Zbigniew Siudak, Artur Dziewierz, Tomasz Rakowski, Dariusz Dudek, Stanisław Bartuś
Pol Arch Intern Med. 2018, Vol. 128, No. 1: 24–34; DOI: 10.20452/pamw.4145
Genetic predictors associated with diabetic retinopathy in patients with diabetic foot
Beata Mrozikiewicz-Rakowska, Magdalena Łukawska, Piotr Nehring, Konrad Szymański, Agnieszka Sobczyk-Kopcioł, Monika Krzyżewska, Paweł Maroszek, Rafał Płoski, Leszek Czupryniak
Pol Arch Intern Med. 2018, Vol. 128, No. 1: 35–42; DOI: 10.20452/pamw.4144
Leukotriene biosynthesis in coronary artery disease. Results of the Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) study
Edyta Stodółkiewicz, Barbara Rewerska, Marcin Rzeszutko, Marek Tomala, Anton Chrustowicz, Krzysztof Żmudka, Marek Sanak, Wojciech Szczeklik
Pol Arch Intern Med. 2018, Vol. 128, No. 1: 43–51; DOI: 10.20452/pamw.4140
Stent thrombosis in patients with drug‑‑eluting stents and bioresorbable vascular scaffolds: the feared complication
Laura S. Kerkmeijer, Erhan Tenekecioglu, Joanna J. Wykrzykowska
Pol Arch Intern Med. 2018, Vol. 128, No. 1: 52–59; DOI: 10.20452/pamw.4180
Endoscopy ultrasound‑guided hepatogastrostomy as an alternative treatment in a patient with cholangiocarcinoma and failure of endoscopic retrograde cholangiopancreatography
Łukasz Krupa, Robert Staroń, Małgorzata Wojnicka‑Stolarz, Jacek Lepiech, Dorota Gutkowska, Krzysztof Gutkowski
Pol Arch Intern Med. 2018, Vol. 128, No. 1: 60–61; DOI: 10.20452/pamw.4190
Apical pseudoaneurysm after transapical transcatheter aortic valve implantation
Agata Krawczyk-Ożóg, Danuta Sorysz, Artur Dziewierz, Renata Rajtar-Salwa, Marzena Daniec, Dariusz Dudek
Pol Arch Intern Med. 2018, Vol. 128, No. 1: 62–63; DOI: 10.20452/pamw.4164
Tumor of the Turkish saddle with endocrine disorders as the first manifestation of gastric adenocarcinoma
Joanna Paleń, Anna Kurzyńska, Małgorzata Trofimiuk‑Müldner, Anna Grochowska, Alicja Hubalewska‑Dydejczyk, Elwira Przybylik‑Mazurek
Pol Arch Intern Med. 2018, Vol. 128, No. 1: 64–65; DOI: 10.20452/pamw.4192
Cerebellar metastasis with the cavity of both components of lung adenosquamous cell carcinoma
Ryota Mashiko, Yasushi Shibata, Norio Takayashiki, Hiroaki Satoh
Pol Arch Intern Med. 2018, Vol. 128, No. 1: 66–68; DOI: 10.20452/pamw.4184
An increase in high‑density lipoprotein cholesterol concentration after initiation of insulin treatment is dose‑dependent in newly diagnosed type 1 diabetes. The results of the InLipoDiab1 study
Aleksandra Cieluch, Aleksandra Uruska, Agata Grzelka, Dorota Zozulińska‑Ziółkiewicz
Pol Arch Intern Med. 2018, Vol. 128, No. 1: 69–71; DOI: 10.20452/pamw.4183